CD8A and neoplasm: In comparison to the mice with FMT from short-term survival PDAC patients, the mice that received FMT from long-term survival donors exhibited a significant reduction of tumor growth accompanied by a significantly higher number of CD8+ cells and activated T cells and higher serum levels of INFγ and IL-2.